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2002). In other words, conformational heterogeneity
breeds functional versatility in proteins.
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through interaction with overexpressed mitogenic re-
ceptors or activated kinases (Borrello et al., 1994; Goga
et al., 1995; Rozakis-Adcock et al., 1992). Hyperphos-Summary
phorylation of p52Shc is observed in many different types
of tumors (Pelicci et al., 1995; Stevenson and Frackelton,The notion that certain proteins lack intrinsic globular
structure under physiological conditions and that the 1998). Cell transformation by polyoma virus middle
T-antigen requires its association with p52Shc, but notattainment of fully folded structure only occurs upon
the binding of target molecules has been recently gain- p46Shc, via the PTB domain (Dilworth et al., 1994). Fur-
thermore, signaling via insulin receptor (Okada et al.,ing popularity. We report here the solution structure
of the PTB domain of the signaling protein Shc in the 1995) or the cytosolic protein tyrosine phosphatase
PTP-PEST (Habib et al., 1994) is dependent on theirfree form. Comparison of this structure with that of
the complex form, obtained previously with a phos- binding to the PTB domain of p52Shc but not p46Shc.
The PTB domain recognizes activated and tyrosine-phopeptide ligand, reveals that the Shc PTB domain
is structurally disordered in the free form, particularly phosphorylated receptors containing a phosphotyro-
sine within the consensus NPXpY motif (Blaikie et al.,around the regions constituting the peptide binding
pocket. The binding of the ligand appears to reorga- 1994; Farooq et al., 1999; Kavanaugh and Williams,
1994; Zhou et al., 1995b). These receptors includenize this pocket through local folding events triggering
a conformational switch between the free and the growth factor, antigen, cytokine, and G protein-coupled
and hormone receptors. The PTB domain of Shc bindscomplex forms.
in a highly specific manner to these receptors and relays
the signal to downstream proteins involved in cellularIntroduction
activities such as cell growth, cell differentiation, and
apoptosis (Batzer et al., 1995; Batzer et al., 1994; vanProteins are not static structures but rather represent
an ensemble of conformations that are in equilibrium der Geer et al., 1995; Kremer et al., 1991; Obermeier et
al., 1994; Okada et al., 1995; Yokote et al., 1994). Forexchange with each other, and such a dynamic system
underlies the structural and functional versatility of these example, binding of the Shc PTB domain to the NPXpY
motif within activated receptors, such as TrkA, ErbB2,molecules. This view is indeed corroborated by several
studies in which protein domains have been shown to ErbB3, and EGFR (Obermeier et al., 1993; Pelicci et al.,
1992; Ricci et al., 1995), enables the Shc protein tobe wholly or partly unstructured in solution and become
structured only upon interaction with their target mole- interact with the SH2 domain of the adaptor protein
Grb2, which in turn binds via its SH3 domain to thecules (Graham et al., 2000; He et al., 2001; Huber and
Weis, 2001; Kim et al., 2000; Lei et al., 2000). Disordered guanine nucleotide exchange factor SOS leading to Ras
activation—a protein that orchestrates and links manyregions in particular are very common among proteins
encoded by the genomes of higher eukaryotes. Struc- different signaling pathways within the cell (Rozakis-
Adcock et al., 1992; Salcini et al., 1994).ture prediction studies indicate that as many as one
in three eukaryote proteins may be at least partially High-resolution structures of PTB domains from sev-
eral proteins including Shc (Zhou et al., 1995b), IRS1disordered in the absence of their binding partners
(Dunker et al., 2001). Thus, disorder in proteins must (Eck et al., 1996; Zhou et al., 1996), X11 (Zhang et al.,
1997), Numb (Li et al., 1998; Zwahlen et al., 2000), SNT1be inherently accompanied by an intrinsic functional
advantage. One argument that has been put forward is (Dhalluin et al., 2000), and Dab1 (Stolt et al., 2003) in
complex with their peptide ligands have been solvedthat the conformational heterogeneity resulting from the
lack of intrinsic globular structure can in principle ac- and shown to share a common structural fold composed
of a central nearly orthogonal antiparallel  sandwichcount for the binding of the same protein domain to
various different target molecules (Dyson and Wright, capped at its C terminus by an amphipathic  helix.
Larger PTB domains such as those of Shc, Numb, and
Dab1 contain accessory structural elements in addition*Correspondence: amjad.farooq@mssm.edu (A.F.), zhoum@inka.
mssm.edu (M.-M.Z.) to the central antiparallel  sandwich capped at its C
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Figure 1. Domain Structure of Shc and the Effects of TrkA Phosphopeptide Binding on the PTB Domain
(A) Alternative splicing of Shc mRNA gives rise to three distinct isoforms: p46Shc, p52Shc, and p66Shc. These differ only to the extent of their
N-terminal sequence. All three isoforms contain an N-terminal phosphotyrosine binding (PTB) domain, a central collagen homology (CH)
domain, and a C-terminal Src homology 2 (SH2) domain. p66Shc isoform contains an additional CH domain N-terminal to the PTB domain. The
PTB domain is mapped to residues 1–207 within the p52Shc isoform.
(B) A superposition of a region of 1H/15N-HSQC showing amide resonances of select residues in the Shc PTB domain (residues 1–207) in the
absence (black) and presence (red) of TrkA phosphopeptide, at a protein to peptide molar ratio of 1:1.
(C) A plot of the difference in the chemical shift values () of the backbone 1HN and 15N resonances of the Shc PTB domain (residues 17–207)
in the free form and complexed to TrkA phosphopeptide as a function of residue number.  for each residue was calculated from the equation
  [(1HN)2  (15N/5)2]1/2, where 1HN and 15N are the chemical shift differences in the 1HN and the 15N resonances of the free and the
complex forms, respectively, as observed in the 1H/15N-HSQC spectra of the Shc PTB domain.
terminus by an helix. An interesting observation to note free form is severely disordered in the absence of its
peptide ligand and that the binding pocket is only con-is that the crystal structures of the IRS-1 PTB domain in
the liganded and unliganded forms indicate that there structed upon the binding of the peptide leading to a
more compact fold in the complex form. How couplingare small but significant differences in the two forms
(Eck et al., 1996). These are largely concentrated in the of folding and binding appears to be a key event in Shc
PTB domain function and implications of this study onloop connecting strands 3 and 4 and in the C-terminal
 helix, which interacts with the ligand. The loop 3-4 possible disorder regions in other PTB domains are dis-
cussed.appears to be more flexible, while the C-terminal  helix
is one turn shorter in the unliganded form. Additionally,
the penultimate turn of this helix is also poorly ordered in Results and Discussion
the unliganded structure. To what extent ligand binding
controls the formation of the intrinsic globular fold in Peptide Binding
The Shc PTB domain is mapped to residues 1–207 atthe case of other PTB domains has, however, not been
addressed. This is particularly relevant in light of the fact the N terminus of the p52 isoform of Shc protein (Figure
1A). The structure of the Shc PTB domain in complexthat partial structural disordering may be more prevalent
in the case of larger PTB domains in the absence of with a 12 residue tyrosine-phosphorylated peptide
(HIIENPQpYFSDA), derived from the Shc binding site ofligand.
In this study, we report a high-resolution solution the nerve growth factor receptor TrKA, reveals that the
structured core region of the domain is composed ofstructure of the Shc PTB domain in the free form and
compare it to the structure of the complex form obtained residues 40–199, while residues at both the N and C
termini outside this core region are largely unstructuredpreviously (Zhou et al., 1995b). Our data show that the
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Table 1. NMR Statistics for the Free Structure of the Shc PTB Domain (Construct 17–207)
Total experimental restraints 2273
Total NOE distance restraints 2059
Ambiguous 85
Unambiguous 1974
Manually assigned 1155
ARIA assigned 819
Intraresidue 902
Interresidue 1072
Sequential |i  j|  1 362
Medium 2  |i  j|  4 181
Long range |i  j| 	 4 529
Hydrogen bond restraints 102
Dihedral angle restraints 112
Final energies (kcal/mol)a
ETOT 131.8 
 25.8
ENOE 26.4 
 10.9
EDIH 0.7 
 0.7
ELJb 780.5 
 23.2
Ramachandran Plot (%)a Full Moleculed Secondary Structuree
Most favorable region 62.3 
 2.7 93.5 
 2.8
Additionally allowed region 27.0 
 2.5 6.5 
 2.8
Generously allowed region 7.3 
 1.6 0.0 
 0.0
Disallowed region 3.4 
 1.3 0.0 
 0.0
Cartesian Coordinate Rmsd’s (A˚)a,c
Backbone 1.15 
 0.10 0.53 
 0.05
Side chain 1.86 
 0.11 1.12 
 0.10
a Based upon the 20 lowest energy-minimized structures.
b The Lennard-Jones potential was not used during any refinement stage.
c None of these final structures exhibit NOE-derived distance restraint violations greater than 0.5 A˚ or dihedral angle restraint violations greater
than 5.
d Residues 42–191.
e Residues 42–46, 50–57, 59–62, 74–88, 111–114, 120–127, 130–135, 140–143, 164–169, 175–181, and 187–191.
(Zhou et al., 1995b). The extent to which this structural chromatography on a nickel-IDA column, as described
in Experimental Procedures. The backbone and sidefold is dependent upon peptide binding, however, re-
mains largely obscure. chain resonances of the protein were assigned from
standard heteronuclear three-dimensional triple-reso-On the basis of chemical shift dispersion of backbone
amide resonances in the two-dimensional 1H/15N hetero- nance nuclear magnetic resonance (NMR) experiments
(Sattler et al., 1999; Yamazaki et al., 1994). The structurenuclear single quantum coherence (1H/15N-HSQC) spec-
tra, the free Shc PTB domain appears to be structurally of the free Shc PTB domain was determined from a total
of 2273 NMR-derived distance, hydrogen bonding, andfolded. Comparison of 1H/15N-HSQC spectra of the Shc
PTB domain in the free form and in complex with TrkA torsional angle restraints (Table 1). A majority of distance
restraints were manually assigned, although ARIA wasphosphopeptide indicated that a large number of amide
resonances, corresponding to residues directly lining also used in the later stages of the calculation. ARIA-
assigned NOEs were manually checked and confirmed.the peptide binding pocket as well as in regions remote
from it, were significantly perturbed upon peptide bind- Unlike the complex form, the core region of the Shc PTB
domain in the free form consists of residues 42–191. Noing (Figures 1B and 1C). This salient observation pro-
vided a strong indication that the free and the bound NOEs were observed between the N- and C-terminal
residues 17–41 and 192–207, and the core region of theforms of the Shc PTB domain may be structurally differ-
ent. In an effort to fully comprehend these differences, domain in the free form of the Shc PTB domain.
In order to provide an assessment of the convergencehigh-resolution three-dimensional structural studies of
the free Shc PTB domain were begun. of the structure of the free Shc PTB domain, superimpo-
sition of the core region of a family of 20 energy-mini-
mized structures derived from the NMR restraints isStructure Determination
The structure of the Shc PTB domain in complex with depicted in Figure 2A. All structures exhibit good geom-
etry, with no violations of distance restraints greaterTrkA peptide was previously obtained using the protein
construct composed of residues 17–207 (Zhou et al., than 0.5 A˚ and no dihedral angle violations larger than
5 (Table 1). The atomic root-mean-square deviations1995b). Thus, to ensure that any structural differences
observed between the free and the bound forms of the (rmsd’s) about the mean coordinate position of the back-
bone and side chain atoms for the secondary structuredomain are not due to the differences in the construct,
we also used the protein construct 17–207 in our current elements are 0.53 
 0.05 A˚ and 1.12 
 0.10 A˚, respec-
tively. Table 1 provides a detailed statistical analysis ofstudies of the free domain. The construct was expressed
in bacterial hosts, and various isotopically (2H, 13C, and the free structure of the Shc PTB domain obtained from
the construct 17–207. Except for the N- and C-terminal15N) labeled protein samples were purified using affinity
Structure
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Figure 2. Comparison of NMR Structures of the Shc PTB Domain (Residues 39–200) in the Free and Complex Forms
Structures of both the free and the complex forms of the PTB domain were obtained using a protein construct composed of residues 17–207.
For clarity, residues 17–38 and 201–207 in the unstructured regions outside the core domain are omitted. Helices and strands are colored
green and blue, respectively. The TrkA phosphopeptide is shown in yellow.
(A) Stereo view of the backbone atoms (N, C, and C) of 20 superimposed energy-minimized NMR-derived structures of the Shc PTB domain
in the free form.
(B) Two alternative ribbon plots, related by a 90 clockwise rotation about the vertical axis, of the Shc PTB domain in the free form are shown.
(C) Two alternative ribbon plots, related by a 90 clockwise rotation about the vertical axis, of the Shc PTB domain complexed to TrkA
phosphopeptide are shown. The orientations of the domain in (B) and (C) are similar. The structure of the Shc PTB domain in complex with
TrkA phosphopeptide was obtained previously (Zhou et al., 1995b), and its atomic coordinates can be found under PDB ID code 1SHC.
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residues 17–41 and 192–207, the overall structures are free form) in the free form not only destroy the cleft
necessary for peptide binding but also reposition thesewell defined.
Given the possibility that the N-terminal residues 1–16 key residues involved in protein-peptide interaction
away from the binding site (Figures 2B and 3A).may be structurally important for the Shc PTB domain,
we also determined the structure of the construct 1–207 Another important feature to note is the loop 2-2
that connects the 2 strand to the helix 2 via a smoothin the free form (data not shown). As expected, the
residues 1–41 were structurally disordered and did not right-handed turn in the complexed form (Figures 2C
and 3B). This topology of the loop 2-2 positions R67appear to have any effect on the structured core region
of the domain. In fact, dynamic properties of this N-ter- at a distance close to pY of the peptide for optimal
electrostatic interactions in the complex form. In theminal region broadened and obscured resonances of
many residues in the 2D and 3D NMR spectra. The struc- free form, however, the loop 2-2 lacks this local con-
formation, resulting in R67 being pulled away by at leastture of PTB domain from the construct 1–207 was virtu-
ally superimposable with that obtained from the con- a few angstroms such that it is no longer optimally posi-
tioned to interact with pY (Figures 2B and 3A). Compari-struct 17–207 in the free form.
son of surface electrostatic potentials of the binding
pocket in the free and the complex forms reveals thatFree Domain Is Structurally Disordered
the latter contains a well-defined hydrophobic grooveFigures 2B and 2C compare the ribbon plots of the Shc
necessary for tight ligand binding, which is missing inPTB domain in the free and the complex forms—both
the case of the free form (Figures 3C and 3D).determined from the construct 17–207. The structure
of the free Shc PTB domain consists of a  sandwich
containing two nearly orthogonal antiparallel  sheets Model for Coupled Folding and Binding
and three  helices. As in the complex form (Zhou et It has been previously shown that the binding of the Shc
al., 1995b), the first  sheet of the  sandwich is com- PTB domain to phosphopeptides is largely governed by
posed of strands 1, 4, 5, and 6. However, the sec- entropic factors (Farooq et al., 1999)—in other words,
ond  sheet of the  sandwich only includes strands some sort of conformational change is involved upon
2, 3, 8, and 9—the 7 strand that forms an intramo- the interaction of the two partners. Our structure of the
lecular antiparallel sheet with 8 and an intermolecular free Shc PTB domain presented here indeed confirms
antiparallel sheet with the TrkA phosphopeptide in the this salient observation. Apart from structural and ther-
complex form is structurally disordered in the free form modynamic information, kinetics also presents a power-
of the Shc PTB domain. ful tool with which the mechanism of protein-peptide
Apart from the disorder of 7, the  sandwich in the interaction can be deciphered. Although little is known
free form is not as tightly packed as it is in the complex about the kinetics of the binding of the Shc PTB domain
form. In the complex form, helices 1 and 3 are packed to TrKA, studies on a related phosphopeptide with a
against one face of the  sandwich creating a hydropho- similar Kd to TrkA indicate that it binds to the Shc PTBbic cleft for peptide binding. In contrast, these helices domain with a rate constant that is much lower than
undergo partial unwinding of between one and two turns binding to SH2 domains, which also interact with phos-
in the free form and are disengaged from creating a phopeptides in a specific manner (Laminet et al., 1996).
hydrophobic cleft necessary for the tight binding of the Thus, the apparently slower association of Shc may be
peptide ligand. The disorder of several key structural a virtue of its ability to undergo partial folding in the
elements and the solvent exposure of many hydropho- presence of its peptide ligand.
bic residues in the free form are evidence of a partially On the basis of structural, thermodynamic, and kinetic
folded or locally disordered state. How such a structur- data discussed above, we have taken the step to ratio-
ally disordered state folds into a fully folded structure nalize the binding of the Shc PTB domain to its peptide
upon peptide binding is best visualized in the form of a ligands in terms of protein folding and binding funnels.
protein movie accessible at http://physbio.mssm.edu/ We believe that ligand binding to the Shc PTB domain
amjad/movies/shcptb/index.html. can be explained by two possible scenarios, both of
which may be in operation. In the first scenario, the free
and the complex forms of the protein are envisaged toLigand-Induced Construction of Binding Pocket
It appears that ligand binding plays a critical role in respectively occupy local and global energy minima in
the protein folding funnel (Figure 4A). These two formsorganizing and constructing a hydrophobic pocket nec-
essary for tight peptide binding. Figure 3 shows how of the protein are structurally distinct. Binding of the
ligand to the free form of the protein enables it to over-the binding pocket becomes severely disrupted and ex-
posed to solvent in the absence of TrkA phosphopep- come the local energy barriers to reach both its fully
folded structure and the global energy minima at thetide. This pocket is composed of an elongated cleft
formed by strand 7, the C-terminal helix 3, and the bottom of the funnel. The structural changes induced
by the ligand would include construction of a peptideloop connecting 2 and 2 (Figures 2C and 3B). In this
cleft, several protein residues including R67, R175, I194, binding pocket through local folding events leading to
the ordering of the 7 strand and winding of helices 1and F198 protrude inward to stabilize the pY (phospho-
tyrosine) and hydrophobic residues N-terminal to the and 2. This scenario would be similar to the so-called
induced-fit mechanism (Kumar et al., 2000; Ma et al.,NPXpY motif within the TrkA phosphopeptide. However,
disorder of strand 7 and unwinding of helix 3 (from 1999; Tsai et al., 1999).
In the second scenario, both the free and the complexthree turns in the complex form to only one turn in the
Structure
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Figure 3. Comparison of the Peptide Binding Pocket in the Free and Complex Forms of the Shc PTB Domain (Residues 39–200)
Key protein residues such as R67, R175, I194, and F198 in the Shc PTB domain that line the peptide binding pocket are shown. Shown are
key peptide residues at positions pY(3) and pY(5), and pY (phosphotyrosine) in the TrkA phosphopeptide that directly interact with the
protein. Also shown are close-up ribbon views of the peptide binding pocket in the free form (A) and the complex form (B), and surface
potential views of the peptide binding pocket in the free form (C) and the complex form (D).
forms of the protein would occupy the local energy min- lin receptors (Batzer et al., 1994; Obermeier et al., 1993,
ima in the folding funnel (Figure 4B). These two forms 1994). The functional versatility of the Shc PTB domain
are considered to be in equilibrium exchange with each thus cannot be overemphasized, but how it achieves
other, although the equilibrium is highly in favor of the this does need some illumination. We believe that the
free form of the protein in the absence of ligand. Ligand structurally disordered state of the free Shc PTB domain
only binds to the complex form without any major struc- may account for its functional versatility, because it
tural rearrangement of the protein, and allows the com- would make it much easier for it to be modified accord-
plex form to overcome the local energy barriers to reach ingly in response to different molecular targets. Given
its global energy minima at the bottom of the funnel. the structural similarity between various functionally dif-
Ligand binding would shift the equilibrium in favor of ferent PTB domains, it is conceivable that other PTB
the complex form such that the free form would undergo domains may also be structurally disordered in their free
the necessary structural changes to become a fully forms.
folded structure resembling that of the complex form The crystal structures of the IRS1 PTB domain in the
while still occupying the local energy minima. This situa- free and bound forms indicate that the differences be-
tion would be similar to the so-called equilibrium shift tween the two forms of the domain are very small com-
mechanism (Kumar et al., 2000; Ma et al., 1999; Tsai et pared to those observed here for the Shc PTB domain
al., 1999). (Eck et al., 1996). Notably, the loop 3-4 is less ordered
and the C-terminal helix (equivalent to 3 in Shc PTB)
is one turn shorter in the free form. IRS1 PTB domain,Biological Implications
however, is based on a minimal, central, nearly orthogo-The Shc PTB domain links many signaling cascades
nal antiparallel  sandwich capped at its C terminus bybetween activated cell surface receptors and intracellu-
an amphipathic  helix. Larger PTB domains such aslar proteins involved in important biological processes.
Numb (Li et al., 1998) and Dab1 (Stolt et al., 2003), whichIt has been shown to interact with a distinct set of growth
receptors including TrkA, ErbB2, ErbB3, EGF, and insu- structurally resemble the Shc PTB domain and contain
Shc PTB Domain
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Figure 4. Folding Funnel View of Ligand
Binding to the Shc PTB Domain
The vertical axis of the funnel denotes the
free energy less the configurational entropy,
while the horizontal axis represents the con-
formational freedom of the protein (indicated
by the width of the wells of the funnel).
(A) The free form lies at local energy minima
in the absence of ligand. Ligand binding in-
duces structural changes within the free form,
allowing it to overcome the local energy barri-
ers to reach the global fold at the bottom of
the funnel.
(B) The free and the complex forms coexist
in the absence of ligand and are in equilibrium
exchange with each other at the local energy
minima in the folding funnel. Ligand binding
to the complex form allows it to overcome
the local energy barriers to reach the global
energy minima at the bottom of the funnel,
while at the same time shifts the equilibrium
from the free to the complex form.
decoupled triple-resonance spectra of HNCA, HN(CO)CA, HNCACB,accessory structural elements in addition to the com-
HN(CO)CACB, and (H)C(CO)NH-TOCSY recorded on a uniformlymon central  sandwich capped at its C terminus by
15N/13C-labeled and fractionally deuterated protein (Sattler et al.,an  helix, may be prone to significant disorder in the
1999; Yamazaki et al., 1994). The side chain assignments were com-
absence of ligand. In fact, our ongoing studies on the pleted with 3D HCCH-TOCSY (Clore and Gronenborn, 1994) data
SNT PTB domain indicate that the free protein appears collected from a uniformly 15N/13C-labeled protein. NOE-derived dis-
tance restraints were obtained from 15N- or 13C-edited 3D NOESYto be less stable and exhibits poor chemical shift disper-
spectra (Clore and Gronenborn, 1994; Logan et al., 1993). φ-anglesion in the NMR spectra (unpublished data), implying
restraints were determined from 3JHN,H coupling constants measuredthat the domain is likely to be at least partially unstruc-
in a 3D HNHA-J spectrum (Clore and Gronenborn, 1994). Slowlytured in the absence of its peptide ligand. In short, the
exchanging amide protons were identified from a series of 2D
conformational switch demonstrated by the Shc PTB 15N-HSQC spectra recorded after the H2O buffer was changed to
domain here may be shared by other larger PTB domains 2H2O buffer. All NMR spectra were processed with NMRPipe/
NMRDraw (Delaglio et al., 1995) and analyzed by NMRView (Johnsonsuch as Numb and Dab1.
and Blevins, 1994).
Experimental Procedures
Structure CalculationsSample Preparation
Structures of the free Shc PTB domain were calculated with a dis-The Shc PTB domain constructs (residues 1–207 and 17–207) were
tance geometry-simulated annealing protocol using the X-PLORcloned, expressed, and purified using procedures as described pre-
program (Brunger, 1993). The initial structure calculations were per-viously (Zhou et al., 1995a, 1995b). Briefly, each cDNA construct
formed using manually assigned NOE-derived distance restraints.was subcloned into the bacterial expression vector pET15b (Nova-
Hydrogen bond distance restraints were added at a late stage ofgen) with a His tag at the N terminus of the recombinant protein
structural calculations for residues with characteristic NOE patterns.and expressed in Escherichia coli BL21(DE3). The cells were grown
The converged structures were then used for the iterative automatedto an optical density of about 0.6 prior to induction with 0.5 mM
assignment of the NOE spectra by ARIA (Nilges and O’Donoghue,isopropyl-1-thio--D-galactopyranoside for 4 hr at 37C. Uniformly
1998), which integrates with X-PLOR for structure refinement. The15N- and 15N/13C-labeled proteins were prepared by growing bacteria
NOE-derived restraints were categorized based on the observedin a minimal medium containing 15NH4Cl with or without 13C6-glucose.
NOE peak intensities. ARIA-assisted assignments were manuallyA uniformly 15N/13C-labeled and fractionally deuterated protein sam-
checked and confirmed. Hydrogen bond and angular restraints wereple was prepared by using a medium containing 75% 2H2O. After
determined from the 3D HNHA-J experiment and the programharvesting the bacterial cells, the protein was purified by affinity
TALOS (Cornilescu et al., 1999). For the ensemble of the final 20chromatography on a nickel-IDA column (Invitrogen) prior to treat-
NMR structures, no distance or torsional angle restraint was violatedment with thrombin to remove the His tag. The cleaved protein was
by more than 0.5 A˚ or 5, respectively.over 95% pure as judged by SDS-PAGE analysis. TrkA phosphopep-
tide was prepared on a MilliGen 9050 peptide synthesizer (Perkin
Elmer) with Fmoc/HBTU chemistry. Phosphotyrosine was incorpo- Acknowledgments
rated using the reagent Fmoc-Tyr(PO3H2) with HBTU/HOAt activa-
tion. The peptide was purified by reverse-phase high performance We thank I. Wolf for peptide synthesis and O. Plotnikova for technical
liquid chromatography and its purity checked by mass spec- advice and support. This work was supported by an American Can-
trometry. cer Society grant to M.-M.Z. A.F. is a recipient of a Wellcome Trust
Fellowship.
NMR Spectroscopy
NMR samples typically contained 0.5 mM protein in 50 mM sodium
phosphate and 20 mM DTT-d10 in H2O/2H2O (9/1) at pH 6.5. All NMR Received: December 20, 2002
Revised: May 7, 2003spectra were acquired at 35C on a 600 MHz or 500 MHz Bruker
DRX NMR spectrometer. The backbone and side chain 1H, 13C, and Accepted: May 12, 2003
Published: August 5, 200315N resonances of the protein were assigned using deuterium-
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